Contrast Media&Contrast Agents-Global Market Status and Trend Report 2013-2023
Report Summary
Contrast Media&Contrast Agents-Global Market Status and Trend Report 2013-2023 offers a comprehensive analysis on Contrast Media&Contrast Agents industry, standing on the readers? perspective, delivering detailed market data and penetrating insights. No matter the client is industry insider, potential entrant or investor, the report will provides useful data and information. Key questions answered by this report include:
Worldwide and Regional Market Size of Contrast Media&Contrast Agents 2013-2017, and development forecast 2018-2023
Main manufacturers/suppliers of Contrast Media&Contrast Agents worldwide, with company and product introduction, position in the Contrast Media&Contrast Agents market
Market status and development trend of Contrast Media&Contrast Agents by types and applications
Cost and profit status of Contrast Media&Contrast Agents, and marketing status
Market growth drivers and challenges
The report segments the global Contrast Media&Contrast Agents market as:
Global Contrast Media&Contrast Agents Market: Regional Segment Analysis (Regional Production Volume, Consumption Volume, Revenue and Growth Rate 2013-2023):
North America
Europe
China
Japan
Rest APAC
Latin America
Global Contrast Media&Contrast Agents Market: Type Segment Analysis (Consumption Volume, Average Price, Revenue, Market Share and Trend 2013-2023):
Iodinated
Gadolinium
Barium
Microbubble
Global Contrast Media&Contrast Agents Market: Application Segment Analysis (Consumption Volume and Market Share 2013-2023; Downstream Customers and Market Analysis)
Radiology
Interventional Radiology
Interventional Cardiology
Global Contrast Media&Contrast Agents Market: Manufacturers Segment Analysis (Company and Product introduction, Contrast Media&Contrast Agents Sales Volume, Revenue, Price and Gross Margin):
GE Healthcare
Bayer AG
Bracco Imaging S.P.A.
Guerbet Group
Lantheus Medical Imaging (Subsidiary of Lantheus Holdings, Inc.)
Nanopet Pharma GmbH
CMC Contrast AB
Daiichi Sankyo
Subhra Pharma Private Limited
Spago Nanomedical AB
In a word, the report provides detailed statistics and analysis on the state of the industry; and is a valuable source of guidance and direction for companies and individuals interested in the market.
Contrast Media&Contrast Agents-Global Market Status and Trend Report 2013-2023 offers a comprehensive analysis on Contrast Media&Contrast Agents industry, standing on the readers? perspective, delivering detailed market data and penetrating insights. No matter the client is industry insider, potential entrant or investor, the report will provides useful data and information. Key questions answered by this report include:
Worldwide and Regional Market Size of Contrast Media&Contrast Agents 2013-2017, and development forecast 2018-2023
Main manufacturers/suppliers of Contrast Media&Contrast Agents worldwide, with company and product introduction, position in the Contrast Media&Contrast Agents market
Market status and development trend of Contrast Media&Contrast Agents by types and applications
Cost and profit status of Contrast Media&Contrast Agents, and marketing status
Market growth drivers and challenges
The report segments the global Contrast Media&Contrast Agents market as:
Global Contrast Media&Contrast Agents Market: Regional Segment Analysis (Regional Production Volume, Consumption Volume, Revenue and Growth Rate 2013-2023):
North America
Europe
China
Japan
Rest APAC
Latin America
Global Contrast Media&Contrast Agents Market: Type Segment Analysis (Consumption Volume, Average Price, Revenue, Market Share and Trend 2013-2023):
Iodinated
Gadolinium
Barium
Microbubble
Global Contrast Media&Contrast Agents Market: Application Segment Analysis (Consumption Volume and Market Share 2013-2023; Downstream Customers and Market Analysis)
Radiology
Interventional Radiology
Interventional Cardiology
Global Contrast Media&Contrast Agents Market: Manufacturers Segment Analysis (Company and Product introduction, Contrast Media&Contrast Agents Sales Volume, Revenue, Price and Gross Margin):
GE Healthcare
Bayer AG
Bracco Imaging S.P.A.
Guerbet Group
Lantheus Medical Imaging (Subsidiary of Lantheus Holdings, Inc.)
Nanopet Pharma GmbH
CMC Contrast AB
Daiichi Sankyo
Subhra Pharma Private Limited
Spago Nanomedical AB
In a word, the report provides detailed statistics and analysis on the state of the industry; and is a valuable source of guidance and direction for companies and individuals interested in the market.
CHAPTER 1 OVERVIEW OF CONTRAST MEDIA&CONTRAST AGENTS
1.1 Definition of Contrast Media&Contrast Agents in This Report
1.2 Commercial Types of Contrast Media&Contrast Agents
1.2.1 Iodinated
1.2.2 Gadolinium
1.2.3 Barium
1.2.4 Microbubble
1.3 Downstream Application of Contrast Media&Contrast Agents
1.3.1 Radiology
1.3.2 Interventional Radiology
1.3.3 Interventional Cardiology
1.4 Development History of Contrast Media&Contrast Agents
1.5 Market Status and Trend of Contrast Media&Contrast Agents 2013-2023
1.5.1 Global Contrast Media&Contrast Agents Market Status and Trend 2013-2023
1.5.2 Regional Contrast Media&Contrast Agents Market Status and Trend 2013-2023
CHAPTER 2 GLOBAL MARKET STATUS AND FORECAST BY REGIONS
2.1 Market Development of Contrast Media&Contrast Agents 2013-2017
2.2 Production Market of Contrast Media&Contrast Agents by Regions
2.2.1 Production Volume of Contrast Media&Contrast Agents by Regions
2.2.2 Production Value of Contrast Media&Contrast Agents by Regions
2.3 Demand Market of Contrast Media&Contrast Agents by Regions
2.4 Production and Demand Status of Contrast Media&Contrast Agents by Regions
2.4.1 Production and Demand Status of Contrast Media&Contrast Agents by Regions 2013-2017
2.4.2 Import and Export Status of Contrast Media&Contrast Agents by Regions 2013-2017
CHAPTER 3 GLOBAL MARKET STATUS AND FORECAST BY TYPES
3.1 Production Volume of Contrast Media&Contrast Agents by Types
3.2 Production Value of Contrast Media&Contrast Agents by Types
3.3 Market Forecast of Contrast Media&Contrast Agents by Types
CHAPTER 4 GLOBAL MARKET STATUS AND FORECAST BY DOWNSTREAM INDUSTRY
4.1 Demand Volume of Contrast Media&Contrast Agents by Downstream Industry
4.2 Market Forecast of Contrast Media&Contrast Agents by Downstream Industry
CHAPTER 5 MARKET DRIVING FACTOR ANALYSIS OF CONTRAST MEDIA&CONTRAST AGENTS
5.1 Global Economy Situation and Trend Overview
5.2 Contrast Media&Contrast Agents Downstream Industry Situation and Trend Overview
CHAPTER 6 CONTRAST MEDIA&CONTRAST AGENTS MARKET COMPETITION STATUS BY MAJOR MANUFACTURERS
6.1 Production Volume of Contrast Media&Contrast Agents by Major Manufacturers
6.2 Production Value of Contrast Media&Contrast Agents by Major Manufacturers
6.3 Basic Information of Contrast Media&Contrast Agents by Major Manufacturers
6.3.1 Headquarters Location and Established Time of Contrast Media&Contrast Agents Major Manufacturer
6.3.2 Employees and Revenue Level of Contrast Media&Contrast Agents Major Manufacturer
6.4 Market Competition News and Trend
6.4.1 Merger, Consolidation or Acquisition News
6.4.2 Investment or Disinvestment News
6.4.3 New Product Development and Launch
CHAPTER 7 CONTRAST MEDIA&CONTRAST AGENTS MAJOR MANUFACTURERS INTRODUCTION AND MARKET DATA
7.1 GE Healthcare
7.1.1 Company profile
7.1.2 Representative Contrast Media&Contrast Agents Product
7.1.3 Contrast Media&Contrast Agents Sales, Revenue, Price and Gross Margin of GE Healthcare
7.2 Bayer AG
7.2.1 Company profile
7.2.2 Representative Contrast Media&Contrast Agents Product
7.2.3 Contrast Media&Contrast Agents Sales, Revenue, Price and Gross Margin of Bayer AG
7.3 Bracco Imaging S.P.A.
7.3.1 Company profile
7.3.2 Representative Contrast Media&Contrast Agents Product
7.3.3 Contrast Media&Contrast Agents Sales, Revenue, Price and Gross Margin of Bracco Imaging S.P.A.
7.4 Guerbet Group
7.4.1 Company profile
7.4.2 Representative Contrast Media&Contrast Agents Product
7.4.3 Contrast Media&Contrast Agents Sales, Revenue, Price and Gross Margin of Guerbet Group
7.5 Lantheus Medical Imaging (Subsidiary of Lantheus Holdings, Inc.)
7.5.1 Company profile
7.5.2 Representative Contrast Media&Contrast Agents Product
7.5.3 Contrast Media&Contrast Agents Sales, Revenue, Price and Gross Margin of Lantheus Medical Imaging (Subsidiary of Lantheus Holdings, Inc.)
7.6 Nanopet Pharma GmbH
7.6.1 Company profile
7.6.2 Representative Contrast Media&Contrast Agents Product
7.6.3 Contrast Media&Contrast Agents Sales, Revenue, Price and Gross Margin of Nanopet Pharma GmbH
7.7 CMC Contrast AB
7.7.1 Company profile
7.7.2 Representative Contrast Media&Contrast Agents Product
7.7.3 Contrast Media&Contrast Agents Sales, Revenue, Price and Gross Margin of CMC Contrast AB
7.8 Daiichi Sankyo
7.8.1 Company profile
7.8.2 Representative Contrast Media&Contrast Agents Product
7.8.3 Contrast Media&Contrast Agents Sales, Revenue, Price and Gross Margin of Daiichi Sankyo
7.9 Subhra Pharma Private Limited
7.9.1 Company profile
7.9.2 Representative Contrast Media&Contrast Agents Product
7.9.3 Contrast Media&Contrast Agents Sales, Revenue, Price and Gross Margin of Subhra Pharma Private Limited
7.10 Spago Nanomedical AB
7.10.1 Company profile
7.10.2 Representative Contrast Media&Contrast Agents Product
7.10.3 Contrast Media&Contrast Agents Sales, Revenue, Price and Gross Margin of Spago Nanomedical AB
CHAPTER 8 UPSTREAM AND DOWNSTREAM MARKET ANALYSIS OF CONTRAST MEDIA&CONTRAST AGENTS
8.1 Industry Chain of Contrast Media&Contrast Agents
8.2 Upstream Market and Representative Companies Analysis
8.3 Downstream Market and Representative Companies Analysis
CHAPTER 9 COST AND GROSS MARGIN ANALYSIS OF CONTRAST MEDIA&CONTRAST AGENTS
9.1 Cost Structure Analysis of Contrast Media&Contrast Agents
9.2 Raw Materials Cost Analysis of Contrast Media&Contrast Agents
9.3 Labor Cost Analysis of Contrast Media&Contrast Agents
9.4 Manufacturing Expenses Analysis of Contrast Media&Contrast Agents
CHAPTER 10 MARKETING STATUS ANALYSIS OF CONTRAST MEDIA&CONTRAST AGENTS
10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
10.2.1 Pricing Strategy
10.2.2 Brand Strategy
10.2.3 Target Client
10.3 Distributors/Traders List
CHAPTER 11 REPORT CONCLUSION
CHAPTER 12 RESEARCH METHODOLOGY AND REFERENCE
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Reference
1.1 Definition of Contrast Media&Contrast Agents in This Report
1.2 Commercial Types of Contrast Media&Contrast Agents
1.2.1 Iodinated
1.2.2 Gadolinium
1.2.3 Barium
1.2.4 Microbubble
1.3 Downstream Application of Contrast Media&Contrast Agents
1.3.1 Radiology
1.3.2 Interventional Radiology
1.3.3 Interventional Cardiology
1.4 Development History of Contrast Media&Contrast Agents
1.5 Market Status and Trend of Contrast Media&Contrast Agents 2013-2023
1.5.1 Global Contrast Media&Contrast Agents Market Status and Trend 2013-2023
1.5.2 Regional Contrast Media&Contrast Agents Market Status and Trend 2013-2023
CHAPTER 2 GLOBAL MARKET STATUS AND FORECAST BY REGIONS
2.1 Market Development of Contrast Media&Contrast Agents 2013-2017
2.2 Production Market of Contrast Media&Contrast Agents by Regions
2.2.1 Production Volume of Contrast Media&Contrast Agents by Regions
2.2.2 Production Value of Contrast Media&Contrast Agents by Regions
2.3 Demand Market of Contrast Media&Contrast Agents by Regions
2.4 Production and Demand Status of Contrast Media&Contrast Agents by Regions
2.4.1 Production and Demand Status of Contrast Media&Contrast Agents by Regions 2013-2017
2.4.2 Import and Export Status of Contrast Media&Contrast Agents by Regions 2013-2017
CHAPTER 3 GLOBAL MARKET STATUS AND FORECAST BY TYPES
3.1 Production Volume of Contrast Media&Contrast Agents by Types
3.2 Production Value of Contrast Media&Contrast Agents by Types
3.3 Market Forecast of Contrast Media&Contrast Agents by Types
CHAPTER 4 GLOBAL MARKET STATUS AND FORECAST BY DOWNSTREAM INDUSTRY
4.1 Demand Volume of Contrast Media&Contrast Agents by Downstream Industry
4.2 Market Forecast of Contrast Media&Contrast Agents by Downstream Industry
CHAPTER 5 MARKET DRIVING FACTOR ANALYSIS OF CONTRAST MEDIA&CONTRAST AGENTS
5.1 Global Economy Situation and Trend Overview
5.2 Contrast Media&Contrast Agents Downstream Industry Situation and Trend Overview
CHAPTER 6 CONTRAST MEDIA&CONTRAST AGENTS MARKET COMPETITION STATUS BY MAJOR MANUFACTURERS
6.1 Production Volume of Contrast Media&Contrast Agents by Major Manufacturers
6.2 Production Value of Contrast Media&Contrast Agents by Major Manufacturers
6.3 Basic Information of Contrast Media&Contrast Agents by Major Manufacturers
6.3.1 Headquarters Location and Established Time of Contrast Media&Contrast Agents Major Manufacturer
6.3.2 Employees and Revenue Level of Contrast Media&Contrast Agents Major Manufacturer
6.4 Market Competition News and Trend
6.4.1 Merger, Consolidation or Acquisition News
6.4.2 Investment or Disinvestment News
6.4.3 New Product Development and Launch
CHAPTER 7 CONTRAST MEDIA&CONTRAST AGENTS MAJOR MANUFACTURERS INTRODUCTION AND MARKET DATA
7.1 GE Healthcare
7.1.1 Company profile
7.1.2 Representative Contrast Media&Contrast Agents Product
7.1.3 Contrast Media&Contrast Agents Sales, Revenue, Price and Gross Margin of GE Healthcare
7.2 Bayer AG
7.2.1 Company profile
7.2.2 Representative Contrast Media&Contrast Agents Product
7.2.3 Contrast Media&Contrast Agents Sales, Revenue, Price and Gross Margin of Bayer AG
7.3 Bracco Imaging S.P.A.
7.3.1 Company profile
7.3.2 Representative Contrast Media&Contrast Agents Product
7.3.3 Contrast Media&Contrast Agents Sales, Revenue, Price and Gross Margin of Bracco Imaging S.P.A.
7.4 Guerbet Group
7.4.1 Company profile
7.4.2 Representative Contrast Media&Contrast Agents Product
7.4.3 Contrast Media&Contrast Agents Sales, Revenue, Price and Gross Margin of Guerbet Group
7.5 Lantheus Medical Imaging (Subsidiary of Lantheus Holdings, Inc.)
7.5.1 Company profile
7.5.2 Representative Contrast Media&Contrast Agents Product
7.5.3 Contrast Media&Contrast Agents Sales, Revenue, Price and Gross Margin of Lantheus Medical Imaging (Subsidiary of Lantheus Holdings, Inc.)
7.6 Nanopet Pharma GmbH
7.6.1 Company profile
7.6.2 Representative Contrast Media&Contrast Agents Product
7.6.3 Contrast Media&Contrast Agents Sales, Revenue, Price and Gross Margin of Nanopet Pharma GmbH
7.7 CMC Contrast AB
7.7.1 Company profile
7.7.2 Representative Contrast Media&Contrast Agents Product
7.7.3 Contrast Media&Contrast Agents Sales, Revenue, Price and Gross Margin of CMC Contrast AB
7.8 Daiichi Sankyo
7.8.1 Company profile
7.8.2 Representative Contrast Media&Contrast Agents Product
7.8.3 Contrast Media&Contrast Agents Sales, Revenue, Price and Gross Margin of Daiichi Sankyo
7.9 Subhra Pharma Private Limited
7.9.1 Company profile
7.9.2 Representative Contrast Media&Contrast Agents Product
7.9.3 Contrast Media&Contrast Agents Sales, Revenue, Price and Gross Margin of Subhra Pharma Private Limited
7.10 Spago Nanomedical AB
7.10.1 Company profile
7.10.2 Representative Contrast Media&Contrast Agents Product
7.10.3 Contrast Media&Contrast Agents Sales, Revenue, Price and Gross Margin of Spago Nanomedical AB
CHAPTER 8 UPSTREAM AND DOWNSTREAM MARKET ANALYSIS OF CONTRAST MEDIA&CONTRAST AGENTS
8.1 Industry Chain of Contrast Media&Contrast Agents
8.2 Upstream Market and Representative Companies Analysis
8.3 Downstream Market and Representative Companies Analysis
CHAPTER 9 COST AND GROSS MARGIN ANALYSIS OF CONTRAST MEDIA&CONTRAST AGENTS
9.1 Cost Structure Analysis of Contrast Media&Contrast Agents
9.2 Raw Materials Cost Analysis of Contrast Media&Contrast Agents
9.3 Labor Cost Analysis of Contrast Media&Contrast Agents
9.4 Manufacturing Expenses Analysis of Contrast Media&Contrast Agents
CHAPTER 10 MARKETING STATUS ANALYSIS OF CONTRAST MEDIA&CONTRAST AGENTS
10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
10.2.1 Pricing Strategy
10.2.2 Brand Strategy
10.2.3 Target Client
10.3 Distributors/Traders List
CHAPTER 11 REPORT CONCLUSION
CHAPTER 12 RESEARCH METHODOLOGY AND REFERENCE
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Reference
